Oragenics Inc. (NYSE AMERICAN: OGEN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ORAGENICS INC.

Oragenics Inc. (NYSE AMERICAN: OGEN)
Listen to this Section


$0.61
-0.0030 ( -0.49% ) 16.3K

Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI), also known as concussion, and for treating Niemann Pick Disease Type C (NPC), as well as proprietary powder formulation and an intranasal delivery device.

Clinical Trial Pipeline Stages


Drug Name Stage
ONP-002DetailsTraumatic brain injury Phase 2a

Market Data


Open $0.61
Previous Close $0.61
Volume 16.3K
Market Cap $2.75M
Day Range $0.58 - $0.61
52 Week Range $0.50 - $5.24
Shares Outstanding 4.51M
Change % -0.49%
Net Change ▼ -0.0030
Insider Ownership -0.06%
Exchange NYSE AMERICAN
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2003
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -228,704.00

Date Type Amount Purchased Purchaser
2024-01-02 Sale -75000.00 REDMOND J MICHAEL
2023-12-01 Sale -3500.00 Telling Fred
2023-10-06 Sale -5102.00 GANDOLFO JOHN P
2023-10-06 Sale -5102.00 Cassidy Bruce A. Sr.
2023-08-10 Sale -25000.00 Telling Fred
2023-08-10 Sale -25000.00 POPE CHARLES L
2023-08-10 Sale -25000.00 Murphy Kimberly M
2023-08-10 Sale -25000.00 KOSKI ROBERT C
2023-08-10 Sale -15000.00 Huffman Janet
2023-08-10 Sale -25000.00 DUNTON ALAN W

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Nov 12, 2025
10-q Quarterly Reports 58 Nov 07, 2025
8-k 8K-related 13 Oct 21, 2025
3 Insider transactions 2 Sep 02, 2025
8-k 8K-related 12 Sep 02, 2025
8-k 8K-related 13 Aug 11, 2025
10-q Quarterly Reports 54 Aug 08, 2025
8-k 8K-related 19 Jul 02, 2025
4 Insider transactions 1 Jun 18, 2025
3 Insider transactions 1 Jun 16, 2025

Latest News


× Before browsing our site, please accept our cookies policy